The report provides a detailed analysis essential for establishing a Tolazamide production plant. It encompasses all critical aspects necessary for Tolazamide production, including the cost of Tolazamide production, Tolazamide plant cost, Tolazamide production costs, and the overall Tolazamide production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Tolazamide production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Tolazamide is an antidiabetic drug used to treat type-2 diabetes mellitus. It is a member of the class of drugs called Sulfonylureas. It is an oral hypoglycemic drug that is efficient in decreasing the blood glucose level. It is used in the cases of non-insulin-dependent diabetes mellitus in individuals whose bodies release insulin but are unable to use it. It stimulates the beta cells of the pancreas to release insulin. It is also used in individuals who are unable to respond to other sulfonylurea drugs. It can also be used with other antidiabetic drugs to increase its effects. It is also known to show diuretic effect by increasing urine production. Thus, it finds its application in the pharmaceutical and medical industries.
The procurement of Tolazamide is influenced by its application as an antidiabetic drug in pharmaceutical and medical industries for the treatment of type-2 Diabetes mellitus. The increasing prevalence of Diabetes mellitus worldwide directly affects the demand for Tolazamide. Diabetes mellitus cases are rising due to poor choice of diet and lifestyle, resulting of which there is an increasing demand for the drug. The number of obese patients is increasing, and the population is aging as well, these two factors can also contribute to the demand for increasing Tolazamide. Tolazamide can also be used together with other antidiabetic drugs, thus it increases its efficacy.
Tolazamide is also used as a diuretic to increase urine production, providing for a further source of its demand. Additionally, it appears in different forms, thus results in an increased patient adherence. The technological breakthrough of healthcare facilities also drives the market for Tolazamide. Hence, the industrial Tolazamide procurement is influenced by its application as an antidiabetic drug in pharmaceutical and medical industries, increasing prevalence of Diabetes mellitus, aging population, poor choice of diet and lifestyle, its use together with other antidiabetic drugs, its diuretic action, technological breakthrough, cost-effectiveness, consumer behavior, and market dynamics.
Raw Material for Tolazamide Production
According to the Tolazamide production plant project report, the key raw materials used in the production of Tolazamide include p-toluenesulfonamide - ethylchloroformate.
Production Process of Tolazamide
The extensive Tolazamide production cost report consists of the following major industrial production process:
- Production from p-toluenesulfonamide and ethylchloroformate: The production process of Tolazamide involves the treatment of p-toluenesulfonamide with ethylchloroformate to form ethyl-(p-toluenesulfonyl)carbamate (intermediate). This intermediate is reacted with 1-aminoazepine, to form Tolazamide.
Tolazamide, commonly referred to as Tolinase, is a white to off-white crystalline powder, having the molecular formula C14H21N3O3S and a molecular weight of 311.40 g/mol. Its melting point is in the range 170-173 °C. Its solubility is 65.4mg/L (at 30 °C). It dissolves easily in acetone, readily in chloroform, and only marginally in water. At 25 °C, its pKa value is 3.6, while at 37.5 °C, it is 5.68. The log P value for it is 2.69. Its IUPAC name is 1-(azepan-1-yl)-3-(4-methylphenyl)sulfonylurea. Tolazamide is an oral hypoglycemic used to treat type-2 diabetes mellitus. It lowers blood glucose levels by increasing the release of insulin.